Abstract
Escherichia coli Lon, an ATP-dependent AAA+ protease, recognizes and degrades many different substrates, including the RcsA and SulA regulatory proteins. More than a decade ago, the E240K mutation in the N domain of Lon was shown to prevent degradation of RcsA but not SulA in vivo. Here, we characterize the biochemical properties of the E240K mutant in vitro and present evidence that the effects of this mutation are complex. For example, LonE240K exists almost exclusively as a dodecamer, whereas wild-type Lon equilibrates between hexamers and dodecamers. Moreover, LonE240K displays degradation defects in vitro that do not correlate in any simple fashion with degron identity, substrate stability, or dodecamer formation. The Lon sequence segment near residue 240 is known to undergo nucleotide-dependent conformational changes, and our results suggest that this region may be important for coupling substrate binding with allosteric activation of Lon protease and ATPase activity.
INTRODUCTION
AAA+ proteases play important biological roles in all organisms (1). Inhibition of the AAA+ Lon protease reduces or eliminates virulence in several pathogenic bacteria and is toxic to human lymphoma cells, whereas Lon overexpression improves the life span of some fungi but kills Escherichia coli (2–7). Like most AAA+ proteases, bacterial Lon recognizes substrates by binding to specific amino acid sequences called degrons or degradation tags (8, 9). In E. coli, Lon degrades native regulatory proteins, including the RcsA transcription factor and the SulA inhibitor of cell division, but also appears to be responsible for degrading the majority of misfolded proteins, including β-galactosidase (10–12). The degron that targets RcsA for Lon degradation is unknown, whereas degrons for SulA (called sul20) and β-galactosidase (called β20) have been indentified (8, 13). The binding of different degrons stabilizes enzyme conformations with high or low protease activities, and the latter state may allow Lon to function as a chaperone (14).
E. coli Lon subunits assemble into a homohexamer, which appears to be the minimal unit of proteolytic function (15). Each subunit contains an N-terminal domain, a central AAA+ module, and a C-terminal peptidase domain (16, 17). The active sites for peptide bond cleavage are sequestered within a bowl-like chamber formed by the peptidase domains of the hexamer (17, 18). The hexameric AAA+ ring of Lon appears to regulate access to this chamber by coupling ATP hydrolysis to conformational changes that unfold and translocate substrates through an axial pore and into the chamber (1). The N domain of Lon is required for stable hexamer formation (19, 20), and recent studies suggest that it also stabilizes a dodecamer, with hexamers and dodecamers being populated at physiological Lon concentrations (21). The dodecamer degrades certain substrates as well as the hexamer but degrades other substrates, including casein, at substantially reduced rates (21). Although crystal structures are known for most individual domains of Lon and a low-resolution electron microscopic structure of the dodecamer has been reported (21–24), high-resolution structures of full-length hexamers or dodecamers have not been solved, and it is not known how the N domain stabilizes hexamers or dodecamers or regulates the activities of the Lon catalytic domains.
The E240K mutation in the N domain was isolated in a genetic screen for E. coli Lon variants that inactivated SulA but not RcsA (25). Cells expressing LonE240K from the chromosome showed normal degradation of SulA but displayed reduced degradation and overexpression of RcsA (25). These results are consistent with a model in which the region around residue 240 functions as an RcsA binding site. However, experiments using hydrogen-deuterium exchange and limited proteolysis showed that this region undergoes nucleotide-dependent changes in conformation (26, 27), and thus, the effects of the E240K mutation could be indirect. Here, we characterize the assembly state and activities of LonE240K. This mutant forms a stable dodecamer, which degrades casein as well as the wild-type Lon hexamer and does so much faster than the wild-type dodecamer. We found that LonE240K binds a peptide mimic of the sul20 degron as well as wild-type Lon but displays severe defects in degrading certain sul20-tagged substrates and modest defects in degrading other sul20-tagged substrates. Similar variability was observed in LonE240K degradation of β20-tagged substrates. The E240K mutation also affects the ability of substrates to stimulate ATP hydrolysis by Lon. These results suggest that the Lon dodecamer can exist in multiple conformations with distinct functional properties. However, LonE240K suppresses proteotoxic stress in vivo as well as wild-type Lon, demonstrating that a dodecamer can mediate this biological activity. In combination, our results suggest that specific substrate properties in addition to the identity of the degron play important roles in determining how these proteins interact with Lon and allosterically control ATP hydrolysis and proteolysis.
MATERIALS AND METHODS
Variants of E. coli Lon were cloned into pBAD33. For proteotoxic stress assays (28), the chloramphenicol resistance marker of pBAD33 was replaced with an ampicillin resistance marker from pSH21. Degron-tagged variants of the human titinI27 domain (8, 14, 29, 30) were cloned into a pSH21 vector with an N-terminal His6 tag. β20-cp6-SFGFP and cp6-SFGFP-sul20 (31) were cloned into a pCOLADuet1 vector with an N-terminal His6 tag followed by a PreScission protease site. Mutations were generated by PCR with a QuikChange mutagenesis kit (Stratagene) or standard PCR techniques. Lon variants, cp6-GFP-sul20, β20-cp6-GFP, and titinI27 variants were expressed, purified, and carboxymethylated (if applicable) as described previously (14, 29, 31). Following purification, protein preparations had less than 5% contaminants, determined on the basis of Coomassie blue staining after SDS-PAGE. Assays for degradation and ATP hydrolysis were performed as described previously (8, 14, 30, 31). Binding of a fluorescently labeled sul20 peptide to proteolytically inactive LonS679A was assayed by determination of changes in fluorescence anisotropy. We constructed a His6-tagged fusion of maltose-binding protein (MBP) and RcsA (His6-MBP-RcsA). This fusion protein expressed well and was soluble but did not bind to a Ni2+-nitrilotriacetic acid column. A small fraction bound to amylose resin (New England BioLabs) and was subsequently chromatographed near the excluded volume of a Superdex S75 gel filtration column.
Prior to ultracentrifugation, Lon variants were dialyzed overnight against 50 mM HEPES (pH 7.5), 150 mM NaCl, 10 μM EDTA, and 100 μM Tris(2-carboxyethyl) phosphine. Immediately before loading of samples into dual-sector charcoal-filled Epon centerpieces, 1 mM MgCl2 and 100 μM ATPγS were added. Sedimentation velocity analysis was performed at 16,000 rpm and 20°C in a Beckman Optima XL-1 analytical ultracentrifuge (Biophysical Instrumentation Facility, Massachusetts Institute of Technology [MIT]) using an An60-Ti rotor. The SEDFIT program (32) was used to calculate the continuous distribution of sedimentation coefficients from 0 to 60S at a resolution of 200 scans per concentration with a confidence level of 0.95. Calculations were performed using a Lon partial specific volume of 0.7431 ml/g, a density of 1.00831 g/ml, and a viscosity of 0.010475 P (21).
For the mucoidy assay, E. coli W3110 lon::Kanr cells were transformed with pBAD33 vectors expressing Lon variants from an arabinose promoter. Liquid cultures were grown in Luria-Bertani (LB) broth until early log phase, diluted 1,000-fold in LB broth, and then spread onto minimal medium plates containing 0.4% glycerol (33), 25 μg/ml kanamycin, and 10 μg/ml chloramphenicol. Cells were grown at 30°C for 48 h. The proteotoxic stress assay tests the ability of Lon variants to support 42°C growth of cells lacking the chromosomal lon, clpX, and clpP genes and expressing low levels of the DnaJ and DnaK chaperones (28). Anti-Lon antibodies were a gift from E. Vieux (MIT).
RESULTS
LonE240K forms a stable dodecamer.
We expressed and purified LonE240K and performed sedimentation velocity ultracentrifugation to characterize its oligomeric state. Strikingly, LonE240K sedimented almost exclusively at a position expected for a dodecamer at concentrations in hexamer equivalents ranging from 0.5 to 3 μM (Fig. 1A). At the lowest concentration, LonE240K was greater than 95% dodecameric, allowing calculation of an upper limit of 2.6 nM for the equilibrium constant for dodecamer-hexamer dissociation. Under the same conditions, wild-type Lon sediments as a mixture of hexamers and dodecamers (21). Thus, the E240K mutation in the N domain of Lon stabilizes dodecamers relative to hexamers.
Fig 1.
Biochemical properties of LonE240K. (A) Sedimentation velocity analytical ultracentrifugation of LonE240K at different concentrations (listed as hexamer equivalents [eq.]). Traces were normalized to have a maximum signal equal to 1 and offset on the y axis for clarity. Experiments were performed at 20°C and 16,000 rpm in 50 mM HEPES (pH 7.5), 150 mM NaCl, 0.01 mM EDTA, 0.1 mM Tris(2-carboxyethyl) phosphine, 1 mM MgCl2, and 0.1 mM ATP-γ-S. (B) Initial rates of degradation of FITC-casein type II (50 μM; Sigma) by different concentrations of LonE240K were determined from changes in fluorescence (excitation, 490 nm; emission, 525 nm). Values are means ± SEMs (n ≥ 3). (C) Substrate dependence of degradation of FITC-casein type II by wild-type Lon or LonE240K (0.3 μM hexamer equivalents). Values are means ± SEMs (n = 3). Solid lines are fit to the Hill form of the Michaelis-Menten equation: rate = Vmax/[1 + (Km/[S])n], where [S] is the substrate concentration and n is the Hill constant. (D) Binding of fluorescein-labeled sul20 peptide (200 nM) by wild-type Lon or LonE240K was assayed by determination of changes in fluorescence anisotropy (excitation, 494 nm; emission, 521 nm). Values are means ± SEMs (n ≥ 2) after subtraction of the anisotropy of the free peptide. Solid lines are fits to a hyperbolic binding equation with fitted KDs (equilibrium dissociation constants) of 4.7 ± 0.2 μM (wild-type Lon) and 2.4 ± 0.1 μM (LonE240K).
The wild-type Lon dodecamer degrades fluorescein isothiocyanate (FITC)-casein very poorly compared to the hexamer, and thus, the enzyme-normalized rate of degradation decreases at higher concentrations, where the fraction of dodecamer increases (21). In contrast, we found that the normalized rate of degradation of FITC-casein by LonE240K remained relatively constant over a 20-fold range of enzyme concentrations (Fig. 1B). At a concentration of 0.3 μM, where wild-type Lon is less than 30% dodecameric (21), it degraded FITC-casein with a Vmax of 4.4 min−1 enzyme−1 and a Km of 16 μM (Fig. 1C). At the same concentration, where LonE240K is more than 90% dodecameric, it degraded FITC-casein with roughly similar values of Vmax and Km (Fig. 1C). Thus, with respect to degradation of this substrate, the LonE240K dodecamer behaved like the wild-type hexamer rather than the wild-type dodecamer. These results suggest that the wild-type dodecamer and the E240K dodecamer adopt different conformations, with the identity of residue 240 being an important factor in dictating which of these conformations are populated. As assayed by changes in fluorescence anisotropy, LonE240K and wild-type Lon bound to a fluorescent sul20 peptide with similar affinity (Fig. 1D), indicating that the binding site for the sul20 degron is not occluded or altered substantially in the mutant dodecamer. The maximum anisotropy was higher for LonE240K, consistent with slower tumbling of a stable dodecamer.
LonE240K has selective defects in degrading model substrates.
We attempted to purify His6-MBP-RcsA for biochemical experiments, but it ran in the excluded volume of a gel filtration column, suggesting that it forms soluble aggregates and was not degraded by wild-type Lon. It is possible that aggregation prevents recognition by Lon or that another cellular protein is required for Lon degradation of RcsA.
To determine if the E240K mutation affected degradation of other model substrates, we initially tested degron-tagged titinI27 proteins that had been unfolded by carboxymethylation (CM) of cysteines normally buried in the hydrophobic core (29). Vmax values for LonE240K degradation of CM-titinI27-sul20 and CM-titinI27-β20 were 45% and 70%, respectively, of the values for wild-type Lon degradation, and the mutant Km values were similar to or higher than the wild-type values (Fig. 2A and B; Table 1). Thus, the E240K mutation causes modest defects in the degradation of unfolded titinI27 substrates with sul20 or β20 degrons.
Fig 2.
Lon and LonE240K degradation of degron-tagged CM-titinI27 or cp6-SFGFP proteins. (A) Degradation of CM-titinI27-sul20; (B) degradation CM-titinI27-β20; (C) degradation of cp6-SFGFP-sul20; (D) degradation of β20-cp6-SFGFP. In panels A to D, values are means ± SEMs (n ≥ 2), lines are fit to the Hill form of the Michaelis-Menten equation, and rates were determined by calculation of acid-soluble radioactivity (for 35S-labeled CM-titinI27 substrates) or changes in fluorescence (for cp6-SFGFP substrates). In panels A to D, the Lon or LonE240K enzymes were present at concentrations of 0.3 μM (hexamer equivalents). (E) Initial rates of degradation of cp6-SFGFP-sul20 (20 μM) by different concentrations of wild-type Lon were determined by calculation of changes in fluorescence (excitation, 467 nm; emission, 525 nm). Values are means ± SEMs (n = 3).
Table 1.
Steady-state kinetic parametersa
| Substrate | Enzyme | Proteolysis |
ATP hydrolysis |
||||
|---|---|---|---|---|---|---|---|
| Vmax (min−1 Lon6−1) | Km (μM) | Hill constant | Vmax (min−1 Lon6−1) | Kapp (μM) | Hill constant | ||
| FITC-casein | Lon | 4.4 ± 0.4 | 16 ± 4 | 1.2 ± 0.1 | NDb | ND | ND |
| LonE240K | 3.9 ± 0.5 | 10 ± 3 | 1 ± 0.2 | ND | ND | ND | |
| cp6-SFGFP-sul20 | Lonc | 3.6 ± 0.3 | 13 ± 2 | 1.2 ± 0.1 | 217 ± 16 | 9.3 ± 1.3 | 1.2 ± 0.1 |
| LonE240K | 0.17 ± 0.01 | 29 ± 3 | 1.2 ± 0.1 | 15 ± 1 | 10 ± 2 | 3.3 ± 1.7 | |
| β20-cp6-SFGFP | Lonc | 2.3 ± 0.3 | 21 ± 6 | 1.2 ± 0.2 | 143 ± 5 | 2.6 ± 0.2 | 1.7 ± 0.1 |
| LonE240K | 0.19 ± 0.02 | 25 ± 4 | 1.5 ± 0.2 | 39 ± 4 | 7 ± 3 | ND | |
| CM-titinI27-β20 | Lon | 5.5 ± 0.1 | 18 ± 1 | 1.4 ± 0.1 | 174 ± 7 | 1.6 ± 0.2 | 0.9 ± 0.1 |
| LonE240K | 3.8 ± 0.2 | 20 ± 2 | 1.8 ± 0.2 | 130 ± 10 | 9 ± 2 | 2.5 ± 0.9 | |
| CM-titinI27-sul20 | Lon | 17.1 ± 0.7 | 12 ± 1 | 1.4 ± 0.2 | 200 ± 20 | 0.6 ± 0.1 | 1.3 ± 0.4 |
| LonE240K | 7.5 ± 0.3 | 35 ± 3 | 1.4 ± 0.1 | 240 ± 20 | 16 ± 2 | 1.3 ± 0.1 | |
| V13P-titinI27-sul20 | Lon | 6.7 ± 0.6 | 38 ± 6 | 1.6 ± 0.2 | ND | ND | ND |
| LonE240K | 1.5 ± 0.1 | 34 ± 4 | 1.8 ± 0.2 | ND | ND | ND | |
| Y9P-titinI27-sul20 | Lon | 3.0 ± 0.1 | 29 ± 2 | 1.2 ± 0.1 | ND | ND | ND |
| LonE240K | 1.0 ± 0.1 | 53 ± 8 | 1.3 ± 0.1 | ND | ND | ND | |
| V15P-titinI27-sul20 | Lon | 5.5 ± 0.4 | 55 ± 8 | 1.3 ± 0.1 | ND | ND | ND |
| LonE240K | 0.65 ± 0.06 | 31 ± 5 | 2.3 ± 0.6 | ND | ND | ND | |
| titinI27-sul20 | Lon | 2 ± 0.1 | 29 ± 3 | 1.5 ± 0.2 | 118 ± 5 | 1 ± 0.1 | 1.1 ± 0.1 |
| LonE240K | 1.2 ± 0.1 | 38 ± 3 | 1.4 ± 0.1 | ND | ND | ND | |
Errors are from nonlinear least-squares fitting.
ND, not determined.
Data were taken from reference 31.
Next, we tested LonE240K degradation of two degron-tagged native substrates, cp6-SFGFP-sul20 and β20-cp6-SFGFP (Fig. 2C and D). cp6-SFGFP is a circularly permuted variant of superfolder green fluorescent protein (SFGFP) (31). Strikingly, both substrates were degraded very poorly by LonE240K, with Vmax values being reduced by 10-fold or more relative to those for wild-type Lon and with Kms being similar to or higher than the wild-type values (Fig. 2C and D; Table 1). The severe defect in degradation of cp6-SFGFP-sul20 by the LonE240K dodecamer is not a property shared by the wild-type dodecamer, as enzyme-normalized rates of cp6-SFGFP-sul20 degradation were relatively constant over concentrations of wild-type Lon from 0.125 to 2 μM (Fig. 2E), where the ratio of wild-type dodecamers to hexamers has been shown to increase substantially (21).
Does the E240K mutation cause a general defect in protein unfolding? To test this possibility, we assayed the Lon and LonE240K degradation of a set of sul20-tagged variants of native titinI27 with different thermodynamic and kinetic stabilities (Fig. 3). The Vmax for LonE240K degradation of titinI27-sul20, the most stable variant, was ∼50% of the Vmax for wild-type Lon degradation, a value similar to that achieved with the LonE240K defect in degradation of unfolded CM-titinI27-sul20. Surprisingly, however, LonE240K showed larger defects relative to wild-type Lon in degrading the Y9P, V13P, and V15P titinI27-sul20 variants (Fig. 3). Because the native structures of these substrates are less stable than the structure of titinI27-sul20 (28), LonE240K appears to have greater difficultly in unfolding certain substrates in a way that does not correlate simply with their thermodynamic or kinetic stabilities.
Fig 3.

Degradation of stability variants of titinI27-sul20 by wild-type Lon and LonE240K (0.3 μM hexamer equivalents). Vmax values were determined by fitting the substrate dependence of initial degradation rates (n = 3; determined by calculation of acid-soluble radioactivity using 35S-labeled proteins) to the Hill form of the Michaelis-Menten equation; bars represent the errors of nonlinear least-squares fitting.
Substrate-stimulated ATP hydrolysis by LonE240K.
To address the linkage between substrate degradation and ATP turnover, we measured the stimulation of LonE240K ATP hydrolysis by CM-titinI27-sul20 or CM-titinI27-β20 and observed nearly wild-type levels of ATP hydrolysis at saturating substrate concentrations (Fig. 4A and B; Table 1). However, saturation required substantially higher concentrations of these substrates in comparison to those required for wild-type Lon, even though a sul20 peptide bound LonE240K with an affinity similar to that for wild-type Lon. In contrast, the maximal level of cp6-GFP-sul20 or β20-GFP-cp6 stimulation of ATP hydrolysis by LonE240K was reduced markedly in comparison with that by wild-type Lon (Fig. 4C and D; Table 1). This very low level of ATPase stimulation by native GFP substrates could be the reason for their very slow degradation, or the low rate of degradation could be responsible for the low level of ATPase stimulation. In combination, these results show that the E240K mutation impairs degradation and substrate stimulation of ATPase activity in a manner that depends on the detailed properties of the substrate.
Fig 4.
Substrate stimulation of ATP hydrolysis by Lon or LonE240K (0.15 μM hexamer equivalents). (A) CM-titinI27-sul20 stimulation; (B) CM-titinI27-β20 stimulation; (C) cp6-SFGFP-sul20 stimulation; (D) β20-cp6-SFGFP stimulation. Values are means ± SEMs (n ≥ 3). Lines are fits to the equation rate = basal + amp/[1 + (Km/[S])n], where [S] is the substrate concentration, n is the Hill constant, basal is the ATP-hydrolysis rate in the absence of substrate, and amp is the amplitude of the substrate-enhanced activity.
Activity of LonE240K in vivo.
We cloned Lon, LonE240K, and proteolytically inactive LonS679A into low-copy-number plasmids under the control of an arabinose-inducible promoter, transformed E. coli strains harboring a deletion of the chromosomal lon gene, and tested for a phenotype that depends upon RcsA-activated transcription of enzymes that synthesize capsular polysaccharide (34, 35). Cells without Lon secrete excess polysaccharide and are mucoid. As expected (12, 25), strains expressing wild-type Lon formed nonmucoid colonies, whereas cells expressing LonE240K or harboring an empty vector were mucoid (Fig. 5A). Cells expressing proteolytically inactive LonS679A were also mucoid, suggesting that active degradation is needed to maintain low RcsA levels in this assay. In these experiments, intracellular Lon levels were minimized by the absence of arabinose and were only slightly higher than the normal level of chromosomal Lon, as judged by Western blotting (not shown). We next tested if LonE240K could support the growth of cells subjected to proteotoxic stress by a lack of the ClpXP protease, low levels of the DnaK and DnaJ chaperones, and growth at 42°C (28). Importantly, LonE240K expressed from the low-copy-number plasmid without arabinose induction supported growth as well as wild-type Lon, whereas cells with the empty vector died (Fig. 5B). These results suggest that the Lon activities required to suppress proteotoxic stress can be performed by a dodecamer.
Fig 5.

Assays of activity in vivo. (A) Colony morphology of E. coli W3110 lon::Kanr cells transformed with pBAD33 plasmids expressing Lon, LonE240K, LonS679A, or the empty parental vector; (B) expression of Lon or LonE240K from pBAD33 plasmids but not the empty vector allowed growth at 42°C of a strain expressing reduced levels of DnaK and DnaJ and lacking the chromosomal genes encoding ClpX, ClpP, and Lon.
DISCUSSION
Wild-type Lon is a complex allosteric enzyme that is active both as a hexamer and as a dodecamer (21). However, unlike the Lon hexamer, the dodecamer fails to efficiently degrade the IbpB heat shock protein and FITC-casein. The dodecamer contains ∼45-Å portals that are absent in the hexamer, and it has been proposed that these portals exclude FITC-casein and IbpB, which behave as large complexes in solution (21). LonE240K was originally isolated in a genetic screen as a variant that failed to degrade RcsA but did degrade SulA (25), a phenotype consistent with a simple RcsA-binding defect. However, we found that LonE240K assembles as a stable dodecamer. If RcsA were present as a large complex in the cell, then it might be excluded by the portals of the stable LonE240K dodecamer. Interestingly, however, LonE240K can degrade FITC-casein efficiently and thus must differ in some way from the wild-type dodecamer. One possibility is that LonE240K adopts an altered dodecamer conformation with portals large enough to accommodate FITC-casein. Alternatively, FITC-casein might not be excluded by the entry portals of the wild-type dodecamer but might fail to bind because a docking site is occluded in this structure. By this model, the E240K mutation could unmask a casein-binding site in the dodecamer. Either of these models requires somewhat different structures for the wild-type and E240K dodecamers.
We found that LonE240K degrades many model substrates more slowly than wild-type Lon. Interestingly, however, the magnitude of these defects was highly substrate dependent. For example, the Vmax for LonE240K was ∼70% of the wild-type value for CM-titinI27-β20, ∼60% for titinI27-sulA, ∼44% for CM-titinI27-sul20, ∼35% for Y9P-titinI27-sul20, ∼22% for V13P-titinI27-sul20, ∼12% for V15P-titinI27-sul20, ∼8% for β20-cp6-SFGFP, and ∼5% for cp6-SFGFP-sul20. Defects occurred for substrates bearing β20 and sulA degrons and for denatured and native substrates. Moreover, the size of the defect did not correlate with native thermodynamic stability. Because AAA+ proteases forcibly unfold native substrates, the mechanical stability of the substrate protein near the point of attachment to the degradation tag is likely to be more important than thermodynamic stability (36, 37).
The ability of substrates to stimulate ATP hydrolysis by LonE240K also differs from that for wild-type Lon. For example, LonE240K has wild-type levels of ATP hydrolysis when stimulated by CM-titinI27-sul20 and CM-titinI27-β20, but ∼10-fold higher substrate concentrations are required for maximal stimulation. In contrast, the maximal levels of cp6-GFP-sul20 or β20-GFP-cp6 stimulation of ATP hydrolysis by LonE240K are much lower than those for wild-type Lon. These results suggest that the detailed properties of different substrates play important roles in determining how they interact with and control proteolysis by wild-type and mutant Lon enzymes. Such properties could include the geometric relationship between the position of the primary degron and other regions of the substrate that might interact with different Lon sites, including the axial pore.
The E240K mutation falls within a coiled-coil region of the N domain (residues 232 to 250) that undergoes nucleotide-dependent changes in conformation (25, 26). Because the E240K mutation does not affect binding of a peptide mimic of the sul20 degron but does alter degradation of several sul20-tagged substrates, this sequence change may alter allosteric communication between the sul20 binding site and the sites in the AAA+ module of Lon that bind and hydrolyze ATP to power translocation and unfolding. Indeed, we recently characterized a set of mutations (R33A/E34A/K35A) in the N domain of Lon that prevent binding of a sul20 peptide (38). Interestingly, these mutations cause Vmax defects in degradation of sul20-tagged substrates very similar to those observed for LonE240K. For example, both LonE240K and LonR33A/E34A/K35A degrade cp6-SFGFP-sul20 with Vmax values 5 to 10% of those for wild-type Lon but degrade CM-titinI27-sul20 and titinI27-sul20 with Vmax values 40 to 60% of those for wild-type Lon. Similarly, CM-titinI27-sul20 stimulates ATP hydrolysis by LonE240K and LonR33A/E34A/K35A to maximal levels, similar to wild-type Lon, but 10-fold more substrate is needed to reach these levels for both mutants.
Although the phenotype originally described for LonE240K by Ebel et al. (25) is consistent with a simple change in substrate discrimination, the biochemical properties of the purified enzyme strongly support a model in which the E240K mutation stabilizes Lon dodecamers, reduces the ability of Lon to degrade many model substrates, and alters allosteric communication between substrate binding and regulation of ATP hydrolysis and proteolysis. Nevertheless, LonE240K suppresses proteotoxic stress in vivo as well as wild-type Lon, suggesting that LonE240K dodecamers can execute this biological role. We anticipate that structural studies of the LonE240K dodecamer will provide further insight into the relationship between different Lon conformations and machine function.
ACKNOWLEDGMENTS
We thank D. Barthelme, V. Baytshtok, S. Kim, E. Vieux, and members of the R.T.S. and T.A.B. labs for reagents and helpful discussions and D. Pheasant (MIT Biophysical Instrumentation Center) for help with the analytical ultracentrifugation experiments. T.A.B. is an employee of the Howard Hughes Medical Institute.
This work was supported by NIH grant AI-16982 and by a National Science Foundation graduate research fellowship to M.L.W.
Footnotes
Published ahead of print 11 October 2013
REFERENCES
- 1.Sauer RT, Baker TA. 2011. AAA+ proteases: ATP-fueled machines of protein destruction. Annu. Rev. Biochem. 80:587–612 [DOI] [PubMed] [Google Scholar]
- 2.Goldberg AL, Moerschell RP, Chung CH, Maurizi MR. 1994. ATP-dependent protease La (lon) from Escherichia coli. Methods Enzymol. 244:350–375 [DOI] [PubMed] [Google Scholar]
- 3.Robertson GT, Kovach ME, Allen CA, Ficht TA, Roop RM. 2000. The Brucella abortus Lon functions as a generalized stress response protease and is required for wild-type virulence in BALB/c mice. Mol. Microbiol. 35:577–588 [DOI] [PubMed] [Google Scholar]
- 4.Ingmer H, Brøndsted L. 2009. Proteases in bacterial pathogenesis. Res. Microbiol. 160:704–710 [DOI] [PubMed] [Google Scholar]
- 5.Luce K, Osiewacz HD. 2009. Increasing organismal healthspan by enhancing mitochondrial protein quality control. Nat. Cell Biol. 11:852–858 [DOI] [PubMed] [Google Scholar]
- 6.Breidenstein EBM, Janot L, Strehmel J, Fernandez L, Taylor PK, Kukavica-Ibrulj I, Gellatly SL, Levesque RC, Overhage J, Hancock REW. 2012. The Lon protease is essential for full virulence in Pseudomonas aeruginosa. PLoS One 7:e49123. 10.1371/journal.pone.0049123 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Bernstein SH, Venkatesh S, Li M, Lee J, Lu B, Hilchey SP, Morse KM, Metcalfe HM, Skalska J, Andreeff M, Brookes PS, Suzuki CK. 2012. The mitochondrial ATP-dependent Lon protease: a novel target in lymphoma death mediated by the synthetic triterpenoid CDDO and its derivatives. Blood 119:3321–3329 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Gur E, Sauer RT. 2008. Recognition of misfolded proteins by Lon, a AAA(+) protease. Genes Dev. 22:2267–2277 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Gur E, Sauer RT. 2008. Evolution of the ssrA degradation tag in Mycoplasma: specificity switch to a different protease. Proc. Natl. Acad. Sci. U. S. A. 105:16113–16118 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Gottesman S, Zipser D. 1978. Deg phenotype of Escherichia coli lon mutants. J. Bacteriol. 133:844–851 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Chung CH, Goldberg AL. 1981. The product of the lon (capR) gene in Escherichia coli is the ATP-dependent protease, protease La. Proc. Natl. Acad. Sci. U. S. A. 78:4931–4935 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Torres-Cabassa AS, Gottesman S. 1987. Capsule synthesis in Escherichia coli K-12 is regulated by proteolysis. J. Bacteriol. 169:981–989 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Higashitani A, Ishii Y, Kato Y, Koriuchi K. 1997. Functional dissection of a cell-division inhibitor, SulA, of Escherichia coli and its negative regulation by Lon. Mol. Gen. Genet. 254:351–357 [DOI] [PubMed] [Google Scholar]
- 14.Gur E, Sauer RT. 2009. Degrons in protein substrates program the speed and operating efficiency of the AAA+ Lon proteolytic machine. Proc. Natl. Acad. Sci. U. S. A. 106:18503–18508 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Park SC, Jia B, Yang JK, Van DL, Shao YG, Han SW, Jeon YJ, Chung CH, Cheong GW. 2006. Oligomeric structure of the ATP-dependent protease La (Lon) of Escherichia coli. Mol. Cells 221:129–134 [PubMed] [Google Scholar]
- 16.Rotanova TV, Botos I, Melnikov EE, Rasulova F, Gustchina A, Maurizi MR, Wlodawer A. 2006. Slicing a protease: structural features of the ATP-dependent Lon proteases gleaned from investigations of isolated domains. Protein Sci. 15:1815–1828 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Botos I, Melnikov EE, Cherry S, Tropea JE, Khalatova AG, Rasulova F, Dauter Z, Maurizi MR, Rotanova TV, Wlodawer A, Gustchina A. 2004. The catalytic domain of Escherichia coli Lon protease has a unique fold and a Ser-Lys dyad in the active site. J. Biol. Chem. 279:8140–8148 [DOI] [PubMed] [Google Scholar]
- 18.Cha S-S, An YJ, Lee C-R, Lee HS, Kim Y-G, Kim SJ, Kwon KK, De Donatis GM, Lee J-H, Maurizi MR, Kang SG. 2010. Crystal structure of Lon protease: molecular architecture of gated entry to a sequestered degradation chamber. EMBO J. 29:3520–3530 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Lee AY-L, Hsu C-H, Wu S-H. 2004. Functional domains of Brevibacillus thermoruber lon protease for oligomerization and DNA binding: role of N-terminal and sensor and substrate discrimination domains. J. Biol. Chem. 279:34903–34912 [DOI] [PubMed] [Google Scholar]
- 20.Melnikov EE, Andrianova AG, Morozkin AD, Stepnov AA, Makhovskaya OV, Botos I, Gustchina A, Wlodawer A, Rotanova TV. 2008. Limited proteolysis of E. coli ATP-dependent protease Lon—a unified view of the subunit architecture and characterization of isolated enzyme fragments. Acta Biochim. Pol. 55:281–296 [PMC free article] [PubMed] [Google Scholar]
- 21.Vieux EF, Wohlever ML, Chen JZ, Sauer RT, Baker TA. 2013. Distinct quaternary structures of the AAA+ Lon protease control substrate degradation. Proc. Natl. Acad. Sci. U. S. A. 110:E2002–E2008. 10.1073/pnas.1307066110 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Duman RE, Löwe J. 2010. Crystal structures of Bacillus subtilis Lon protease. J. Mol. Biol. 401:653–670 [DOI] [PubMed] [Google Scholar]
- 23.Li M, Rasulova F, Melnikov EE, Rotanova TV, Gustchina A, Maurizi MR, Wlodawer A. 2005. Crystal structure of the N-terminal domain of E. coli Lon protease. Protein Sci. 14:2895–2900 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Li M, Gustchina A, Rasulova FS, Melnikov EE, Maurizi MR, Rotanova TV, Dauter Z, Wlodawer A. 2010. Structure of the N-terminal fragment of Escherichia coli Lon protease. Acta Crystallogr. D Biol. Crystallogr. 66:865–873 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Ebel W, Skinner MM, Dierksen KP, Scott JM, Trempy JE. 1999. A conserved domain in Escherichia coli Lon protease is involved in substrate discriminator activity. J. Bacteriol. 181:2236–2243 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Cheng I, Mikita N, Fishovitz J, Frase H, Wintrode P, Lee I. 2012. Identification of a region in the N-terminus of Escherichia coli Lon that affects ATPase, substrate translocation and proteolytic activity. J. Mol. Biol. 418:208–225 [DOI] [PubMed] [Google Scholar]
- 27.Vasilyeva OV, Kolygo KB, Leonova YF, Potapenko NA, Ovchinnikova TV. 2002. Domain structure and ATP-induced conformational changes in Escherichia coli protease Lon revealed by limited proteolysis and autolysis. FEBS Lett. 526:66–70 [DOI] [PubMed] [Google Scholar]
- 28.Tomoyasu T, Mogk A, Langen H, Goloubinoff P, Bukau B. 2001. Genetic dissection of the roles of chaperones and proteases in protein folding and degradation in the Escherichia coli cytosol. Mol. Microbiol. 40:397–413 [DOI] [PubMed] [Google Scholar]
- 29.Kenniston JA, Baker TA, Fernandez JM, Sauer RT. 2003. Linkage between ATP consumption and mechanical unfolding during the protein processing reactions of an AAA+ degradation machine. Cell 114:511–520 [DOI] [PubMed] [Google Scholar]
- 30.Gur E, Vishkautzan M, Sauer RT. 2012. Protein unfolding and degradation by the AAA+ Lon protease. Protein Sci. 21:268–278 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Wohlever ML, Nager AR, Baker TA, Sauer RT. 2013. Engineering fluorescent protein substrates for the AAA+ Lon protease. Protein Eng. Des. Sel. 26:299–305 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Brown PH, Schuck P. 2006. Macromolecular size-and-shape distributions by sedimentation velocity analytical ultracentrifugation. Biophys. J. 90:4651–4661 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Davis BD, Mingioli ES. 1950. Mutants of Escherichia coli requiring methionine or vitamin B12. J. Bacteriol. 60:17–28 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Gottesman S, Trisler P, Torres-Cabassa A. 1985. Regulation of capsular polysaccharide synthesis in Escherichia coli K-12: characterization of three regulatory genes. J. Bacteriol. 162:1111–1119 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Van Melderen L, Gottesman S. 1999. Substrate sequestration by a proteolytically inactive Lon mutant. Proc. Natl. Acad. Sci. U. S. A. 96:6064–6071 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Lee C, Schwartz MP, Prakash S, Iwakura M, Matouschek A. 2001. ATP-dependent proteases degrade their substrates by processively unraveling them from the degradation signal. Mol. Cell 7:627–637 [DOI] [PubMed] [Google Scholar]
- 37.Sauer RT. 2013. Mutagenic dissection of the sequence determinants of protein folding, recognition, and machine function. Protein Sci 22:1675–1687 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Wohlever ML. 2013. The role of the N domain in substrate binding, oligomerization, and allosteric regulation of the AAA+ Lon protease. Ph.D. thesis Massachusetts Institute of Technology, Cambridge, MA [Google Scholar]



